EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options

Debora B Mello iD, Fernanda Cristina Paccola Mesquita iD, Danúbia Silva Dos Santos iD, Karina Dutra Asensi iD, Marlon Lemos Dias iD, Antonio Carlos Campos de Carvalho iD, Regina Coeli Dos Santos Goldenberg iD, Tais Hanae Kasai-Brunswick iD

International Journal of Molecular Sciences · 31.05.2024 · 25 (11) · 6063

DOI: 10.3390/ijms25116063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.05.2024. Verfasst von Debora B Mello und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Center of Structural Biology and Bioimaging, CENABIO, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Regenerative Medicine. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, National Institute of Science and Technology in Regenerative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stromal cell (MSC)-based advanced therapy medicinal products (ATMPs) are being tried in a vast range of clinical applications. These cells can be isolated from different donor tissues by using several methods, or they can even be derived from induced pluripotent stem cells or embryonic stem cells. However, ATMP heterogeneity may impact product identity and potency, and, consequently, clinical trial outcomes. In this review, we discuss these topics and the need to establish minimal criteria regarding the manufacturing of MSCs so that these innovative therapeutics may be better positioned to contribute to the advancement of regenerative medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationRegenerative MedicineHumansAnimalsInduced Pluripotent Stem CellsCell Differentiation

Stichwörter der Autor:innen

advanced therapy medicinal productsmesenchymal stromal cellregenerative medicine

Autor:innen und Institutionen

  • National Center of Structural Biology and Bioimaging, CENABIO, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
  • Regenerative Medicine Research Department, The Texas Heart Institute, Houston, TX 77030, USA.
  • Center of Cellular Technology, National Institute of Cardiology, INC, Rio de Janeiro 22240-002, Brazil.
  • National Institute of Science and Technology for Regenerative Medicine-REGENERA, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
  • Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.

ORCID-Profile: Debora B Mello, Fernanda Cristina Paccola Mesquita, Danúbia Silva Dos Santos, Karina Dutra Asensi, Marlon Lemos Dias, Antonio Carlos Campos de Carvalho, Regina Coeli Dos Santos Goldenberg, Tais Hanae Kasai-Brunswick

Förderung

  • National Council for Scientific and Technological Development
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • National Institute of Science and Technology in Regenerative Medicine
  • Coordination of Superior Level Staff Improvement - CAPES
  • Brazilian National Research Council/CNPq
  • Carlos Chagas Rio de Janeiro State Foundation/FAPERJ
  • National Center of Science and Technology for Regenerative Medicine/REGENERA

Zitieren

APA

Mello, D. B., Mesquita, F. C. P., Silva Dos Santos, D., Asensi, K. D., Dias, M. L., Campos de Carvalho, A. C., Goldenberg, R. C. D. S., & Kasai-Brunswick, T. H. (2024). Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options. International Journal of Molecular Sciences, 25(11), 6063. https://doi.org/10.3390/ijms25116063

Vancouver

Mello DB, Mesquita FCP, Silva Dos Santos D, Asensi KD, Dias ML, Campos de Carvalho AC, et al. Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options. International Journal of Molecular Sciences. 2024;25(11):6063. doi:10.3390/ijms25116063

BibTeX
@article{Mello2024,
  author = {Mello, Debora B and Mesquita, Fernanda Cristina Paccola and Silva Dos Santos, Danúbia and Asensi, Karina Dutra and Dias, Marlon Lemos and Campos de Carvalho, Antonio Carlos and Goldenberg, Regina Coeli Dos Santos and Kasai-Brunswick, Tais Hanae},
  title = {Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {11},
  pages = {6063},
  doi = {10.3390/ijms25116063}
}
Kostenlos starten →